You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
SBC: LEUKOGENE THERAPEUTICS INC Topic: 102Project Summary Abstract Multiple Myeloma MM is the second most common form of blood cancer and remains an incurable and deadly disease Proteasome inhibitor PI therapy is a cornerstone in the treatment of MM but resistance to this class of agent is an emerging challenge in the clinic New therapeutic approaches that specifically target resistance are needed to maximize responses and ultimate ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Alkontrol herbal for Treating Alcohol Abuse
SBC: NATURAL PHARMACIA INTERNATIONAL, INC. Topic: NIAAADESCRIPTION provided by applicant This application for a Fast Track STTR award represents a collaboration between Natural Pharmacia International Inc NPI and McLean Hospital to initiate steps toward commercializing a isoflavone botanical product for treating alcoholism Excessive use of alcohol accounts for much of the public health burden related to alcohol use disorders including fetal a ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Real-Time Health Management Portable Sensor for Solid Rocket Motors
SBC: PHYSICAL SCIENCES INC. Topic: MDA14T004Physical Sciences Inc. (PSI) proposes to design, develop, and demonstrate a portable, non-invasive, real-time sensor to assess the chemical and physical health of solid rocket motors as a function of age without affecting the motors integrity nor having direct contact with the propellant. In Phase II, a sensor to monitor specific gas species that are markers of the chemical and mechanical aging pr ...
STTR Phase II 2016 Department of DefenseMissile Defense Agency -
Proteolytic Imaging of Remodeling Myocardium
SBC: Micro Vide, LLC Topic: NHLBIDESCRIPTIONprovided by applicantProteolytic Imaging of Remodeling Myocardium Abstract Heart attacksi emyocardial infarction or MIoccur in more thanmillion patients annuallyAdvances in interventional and pharmacological therapies have dramatically improved survival following the initial MIand patients are often surviving acute MI with more extensive myocardial injuryConsequentlythe number of patien ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Simultaneous Proportional and Independent sEMG Based Hand Wrist Prosthesis Control
SBC: LIBERATING TECHNOLOGIES INC Topic: NICHDDESCRIPTION provided by applicant Surface electromyogram sEMG controlled powered hand wrist prostheses are used by upper limb amputees to return partial upper limb function Conventional transradial prostheses can use surface EMG amplitudes from the residual forearm flexors and extensors to control hand closing and opening respectively Additional degrees of freedom DoFs e g wrist rota ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis
SBC: DERMAXON LLC Topic: NIAMSProject Summary Abstract DermaXon s project goal is to develop efficacious novel selective inhibitors of CYP A for the topical treatment of ichthyosis Congenital ichthyosis is a family of hereditary disorders of keratinization characterized by dry scaling skin that may be thickened or very thin impacting the quality of life of patients and their family members Currently there is no cure f ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Smart Residential Carpet for Promoting Aging in Place
SBC: BIOSENSICS LLC Topic: NIADESCRIPTION provided by applicant Aging in place or the ability of older adults to continue to live safely and economically in their own residences for as long as possible is one of the key issues of modern societies Continued population growth of older adults age will lead to significant financial and logistical burdens on the nationandapos s healthcare system As the population ages ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of PAR Pepducins for the Treatment of Atopic Dermatitis
SBC: OASIS PHARMACEUTICALS, LLC Topic: NIAMSDESCRIPTION provided by applicant Atopic dermatitis AD or severe eczema is a very common life long skin disease with of adults in the US requiring systemic therapy Clinical manifestations of AD include multiple inflamed lesions erosions accompanied by lichenification thick leathery skin fibrotic papules and severely dry skin with increased susceptibility to infection A major uncont ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Therapeutics for inflammatory bowel disease from the microbiome
SBC: SYMBIOTIX BIOTHERAPIES, INC. Topic: 300PROJECT SUMMARY ABSTRACT Interactions between the gut microbiome and the immune system have been linked to inflammatory bowel disease IBD IBD is a chronic and progressive gastrointestinal disease characterized by uncontrolled activation of the intestinal immune system resulting in severe medical complications affecting over million patients in the United States It is a disease of high u ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
T SS needle protein inhibitors for the treatment of P aeruginosa infection
SBC: MICROBIOTIX, INC. Topic: NIAIDDESCRIPTION provided by applicant The inability to treat many Gram negative bacterial infections effectively with existing antibiotics is a major medical crisis Pseudomonas aeruginosa is a prime example of clinical isolates from critically ill patients are resistant to three or more drugs The overall goal of this project is to address the critical medical need by a novel approach of iden ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health